Literature DB >> 16870080

Development and testing of a neuropathic pain screening questionnaire: ID Pain.

Russell Portenoy1.   

Abstract

OBJECTIVE: To develop a patient-completed screening tool to help differentiate nociceptive and neuropathic pain. RESEARCH DESIGN AND METHODS: A multicenter study was performed for item reduction (initial 89-item questionnaire) and model building. Patients (N = 586) with non-headache chronic pain completed the questionnaire and were referred to pain specialists for diagnosis. Factor and regression analyses were used to derive a final, 6-item questionnaire--ID Pain. A second multicenter study evaluated reliability and validity. Patients (N = 308) treated by pain specialists completed ID Pain and validation measures. MAIN OUTCOME MEASURES: Sensitivity and specificity were assessed using receiver operating characteristic curves and the concordance c index. Reliability was assessed using a kappa statistic and intraclass correlation coefficient.
RESULTS: Final 6 items were: did the pain feel: (1) like pins and needles? (2) hot/burning? (3) numb? (4) like electrical shocks? (5) is the pain made worse with the touch of clothing or bed sheets? (6) is the pain limited to your joints? "Yes" answers to questions 1-5 were scored as 1, while a "yes" answer to question 6 was scored as -1. "No" answers were scored as 0. Higher scores (-1 to 5) suggested a neuropathic component. The questionnaire accurately predicted diagnoses of neuropathic pain made by pain specialists. The concordance c indices in the studies were 0.73 and 0.69. The ICC was 0.742; the kappa statistic ranged from 0.742 to 0.527.
CONCLUSIONS: ID Pain appeared to accurately indicate the presence of a neuropathic component of pain. As a brief, self-administered screening tool, it could be useful in primary care settings.

Entities:  

Mesh:

Year:  2006        PMID: 16870080     DOI: 10.1185/030079906X115702

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  72 in total

Review 1.  Phenotyping and genotyping neuropathic pain.

Authors:  Inna Belfer; Feng Dai
Journal:  Curr Pain Headache Rep       Date:  2010-06

2.  Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.

Authors:  Cielito Reyes-Gibby; Phuong Khanh Morrow; Michael I Bennett; Mark P Jensen; Sanjay Shete
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

3.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

4.  [Preoperative, neuropathic component in patients with back pain].

Authors:  Y-J Lee; E M W Koch; J B Breidebach; R Bornemann; D C Wirtz; R Pflugmacher
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

Review 5.  Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.

Authors:  Alex Mu; Erica Weinberg; Dwight E Moulin; Hance Clarke
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

6.  Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer.

Authors:  Kristine L Kwekkeboom; Kristen Abbott-Anderson; Britt Wanta
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

7.  Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain.

Authors:  L Padua; C Briani; A Truini; I Aprile; D Bouhassirà; G Cruccu; S Jann; E Nobile-Orazio; C Pazzaglia; A Morini; M Mondelli; P Ciaramitaro; G Cavaletti; D Cocito; R Fazio; L Santoro; F Galeotti; M Carpo; R Plasmati; L Benedetti; A Schenone
Journal:  Neurol Sci       Date:  2012-03-21       Impact factor: 3.307

8.  A PROMIS Measure of Neuropathic Pain Quality.

Authors:  Robert L Askew; Karon F Cook; Francis J Keefe; Cindy J Nowinski; David Cella; Dennis A Revicki; Esi M Morgan DeWitt; Kaleb Michaud; Dace L Trence; Dagmar Amtmann
Journal:  Value Health       Date:  2016-04-06       Impact factor: 5.725

9.  Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study.

Authors:  Concepción Pérez; María Teresa Saldaña; Ana Navarro; Inma Vilardaga; Javier Rejas
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 10.  Tools for assessing neuropathic pain.

Authors:  Giorgio Cruccu; Andrea Truini
Journal:  PLoS Med       Date:  2009-04-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.